Senti Biosciences, Inc. Common Stock
SNTI •
Sell Closed
Signal type
Sell
Status
Closed
Open Price
$0.79
Closed Price
$0.93
Performance
-17.51%
Days Open
18
Signal Setup
Signal Type Sell
Status Closed
Open Date Mar 27, 2026
Open Price $0.79
Stop Loss $1.57
Timespan Day
Trade Outcome
Closed Status Loss
Closed Date Apr 14, 2026
Closed Price $0.93
Performance -17.51%
Days Open 18
Company Profile
Name Senti Biosciences, Inc. Common Stock
Ticker SNTI
Market Cap $55.03M
Sector BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Latest Close $0.93
List Date Jun 9, 2022
Description
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.
Website Open Company Website